Medical Care
Global Solid Organ Transplantation Rejection (SOT) Market Research Report 2026
- May 01, 26
- ID: 756708
- Pages: 101
- Figures: 103
- Views: 2
This report delivers a comprehensive overview of the global Solid Organ Transplantation Rejection (SOT) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Solid Organ Transplantation Rejection (SOT). The Solid Organ Transplantation Rejection (SOT) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Solid Organ Transplantation Rejection (SOT) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Solid Organ Transplantation Rejection (SOT) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis
Terumo
Roche
Astellas Pharma
Preservation Solutions
Transmedic
Pfizer
Sanofi
Veloxis Pharmaceuticals
Segment by Type
Kidney
Heart
Liver
Segment by Application
Hospital
Transplant Centers
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Solid Organ Transplantation Rejection (SOT) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Solid Organ Transplantation Rejection (SOT) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Solid Organ Transplantation Rejection (SOT) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis
Terumo
Roche
Astellas Pharma
Preservation Solutions
Transmedic
Pfizer
Sanofi
Veloxis Pharmaceuticals
Segment by Type
Kidney
Heart
Liver
Segment by Application
Hospital
Transplant Centers
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Solid Organ Transplantation Rejection (SOT) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Kidney
1.2.3 Heart
1.2.4 Liver
1.3 Market by Application
1.3.1 Global Solid Organ Transplantation Rejection (SOT) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Transplant Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid Organ Transplantation Rejection (SOT) Market Perspective (2021–2032)
2.2 Global Solid Organ Transplantation Rejection (SOT) Growth Trends by Region
2.2.1 Global Solid Organ Transplantation Rejection (SOT) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Solid Organ Transplantation Rejection (SOT) Historic Market Size by Region (2021–2026)
2.2.3 Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Region (2027–2032)
2.3 Solid Organ Transplantation Rejection (SOT) Market Dynamics
2.3.1 Solid Organ Transplantation Rejection (SOT) Industry Trends
2.3.2 Solid Organ Transplantation Rejection (SOT) Market Drivers
2.3.3 Solid Organ Transplantation Rejection (SOT) Market Challenges
2.3.4 Solid Organ Transplantation Rejection (SOT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid Organ Transplantation Rejection (SOT) Players by Revenue
3.1.1 Global Top Solid Organ Transplantation Rejection (SOT) Players by Revenue (2021–2026)
3.1.2 Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Players (2021–2026)
3.2 Global Top Solid Organ Transplantation Rejection (SOT) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Solid Organ Transplantation Rejection (SOT) Revenue
3.4 Global Solid Organ Transplantation Rejection (SOT) Market Concentration Ratio
3.4.1 Global Solid Organ Transplantation Rejection (SOT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid Organ Transplantation Rejection (SOT) Revenue in 2025
3.5 Global Key Players of Solid Organ Transplantation Rejection (SOT) Head Offices and Areas Served
3.6 Global Key Players of Solid Organ Transplantation Rejection (SOT), Products and Applications
3.7 Global Key Players of Solid Organ Transplantation Rejection (SOT), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Solid Organ Transplantation Rejection (SOT) Breakdown Data by Type
4.1 Global Solid Organ Transplantation Rejection (SOT) Historic Market Size by Type (2021–2026)
4.2 Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Type (2027–2032)
5 Solid Organ Transplantation Rejection (SOT) Breakdown Data by Application
5.1 Global Solid Organ Transplantation Rejection (SOT) Historic Market Size by Application (2021–2026)
5.2 Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)
6.2 North America Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)
6.4 North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)
7.2 Europe Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)
7.4 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)
8.2 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (2021–2026)
8.4 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)
9.2 Latin America Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)
9.4 Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)
10.2 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)
10.4 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Solid Organ Transplantation Rejection (SOT) Introduction
11.1.4 Novartis Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 Terumo
11.2.1 Terumo Company Details
11.2.2 Terumo Business Overview
11.2.3 Terumo Solid Organ Transplantation Rejection (SOT) Introduction
11.2.4 Terumo Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.2.5 Terumo Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Solid Organ Transplantation Rejection (SOT) Introduction
11.3.4 Roche Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.3.5 Roche Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Solid Organ Transplantation Rejection (SOT) Introduction
11.4.4 Astellas Pharma Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.4.5 Astellas Pharma Recent Development
11.5 Preservation Solutions
11.5.1 Preservation Solutions Company Details
11.5.2 Preservation Solutions Business Overview
11.5.3 Preservation Solutions Solid Organ Transplantation Rejection (SOT) Introduction
11.5.4 Preservation Solutions Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.5.5 Preservation Solutions Recent Development
11.6 Transmedic
11.6.1 Transmedic Company Details
11.6.2 Transmedic Business Overview
11.6.3 Transmedic Solid Organ Transplantation Rejection (SOT) Introduction
11.6.4 Transmedic Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.6.5 Transmedic Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Solid Organ Transplantation Rejection (SOT) Introduction
11.7.4 Pfizer Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.7.5 Pfizer Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Solid Organ Transplantation Rejection (SOT) Introduction
11.8.4 Sanofi Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.8.5 Sanofi Recent Development
11.9 Veloxis Pharmaceuticals
11.9.1 Veloxis Pharmaceuticals Company Details
11.9.2 Veloxis Pharmaceuticals Business Overview
11.9.3 Veloxis Pharmaceuticals Solid Organ Transplantation Rejection (SOT) Introduction
11.9.4 Veloxis Pharmaceuticals Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.9.5 Veloxis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Kidney
1.2.3 Heart
1.2.4 Liver
1.3 Market by Application
1.3.1 Global Solid Organ Transplantation Rejection (SOT) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Transplant Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid Organ Transplantation Rejection (SOT) Market Perspective (2021–2032)
2.2 Global Solid Organ Transplantation Rejection (SOT) Growth Trends by Region
2.2.1 Global Solid Organ Transplantation Rejection (SOT) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Solid Organ Transplantation Rejection (SOT) Historic Market Size by Region (2021–2026)
2.2.3 Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Region (2027–2032)
2.3 Solid Organ Transplantation Rejection (SOT) Market Dynamics
2.3.1 Solid Organ Transplantation Rejection (SOT) Industry Trends
2.3.2 Solid Organ Transplantation Rejection (SOT) Market Drivers
2.3.3 Solid Organ Transplantation Rejection (SOT) Market Challenges
2.3.4 Solid Organ Transplantation Rejection (SOT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid Organ Transplantation Rejection (SOT) Players by Revenue
3.1.1 Global Top Solid Organ Transplantation Rejection (SOT) Players by Revenue (2021–2026)
3.1.2 Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Players (2021–2026)
3.2 Global Top Solid Organ Transplantation Rejection (SOT) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Solid Organ Transplantation Rejection (SOT) Revenue
3.4 Global Solid Organ Transplantation Rejection (SOT) Market Concentration Ratio
3.4.1 Global Solid Organ Transplantation Rejection (SOT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid Organ Transplantation Rejection (SOT) Revenue in 2025
3.5 Global Key Players of Solid Organ Transplantation Rejection (SOT) Head Offices and Areas Served
3.6 Global Key Players of Solid Organ Transplantation Rejection (SOT), Products and Applications
3.7 Global Key Players of Solid Organ Transplantation Rejection (SOT), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Solid Organ Transplantation Rejection (SOT) Breakdown Data by Type
4.1 Global Solid Organ Transplantation Rejection (SOT) Historic Market Size by Type (2021–2026)
4.2 Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Type (2027–2032)
5 Solid Organ Transplantation Rejection (SOT) Breakdown Data by Application
5.1 Global Solid Organ Transplantation Rejection (SOT) Historic Market Size by Application (2021–2026)
5.2 Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)
6.2 North America Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)
6.4 North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)
7.2 Europe Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)
7.4 Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)
8.2 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (2021–2026)
8.4 Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)
9.2 Latin America Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)
9.4 Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size (2021–2032)
10.2 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (2021–2026)
10.4 Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Solid Organ Transplantation Rejection (SOT) Introduction
11.1.4 Novartis Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 Terumo
11.2.1 Terumo Company Details
11.2.2 Terumo Business Overview
11.2.3 Terumo Solid Organ Transplantation Rejection (SOT) Introduction
11.2.4 Terumo Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.2.5 Terumo Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Solid Organ Transplantation Rejection (SOT) Introduction
11.3.4 Roche Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.3.5 Roche Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Solid Organ Transplantation Rejection (SOT) Introduction
11.4.4 Astellas Pharma Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.4.5 Astellas Pharma Recent Development
11.5 Preservation Solutions
11.5.1 Preservation Solutions Company Details
11.5.2 Preservation Solutions Business Overview
11.5.3 Preservation Solutions Solid Organ Transplantation Rejection (SOT) Introduction
11.5.4 Preservation Solutions Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.5.5 Preservation Solutions Recent Development
11.6 Transmedic
11.6.1 Transmedic Company Details
11.6.2 Transmedic Business Overview
11.6.3 Transmedic Solid Organ Transplantation Rejection (SOT) Introduction
11.6.4 Transmedic Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.6.5 Transmedic Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Solid Organ Transplantation Rejection (SOT) Introduction
11.7.4 Pfizer Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.7.5 Pfizer Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Solid Organ Transplantation Rejection (SOT) Introduction
11.8.4 Sanofi Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.8.5 Sanofi Recent Development
11.9 Veloxis Pharmaceuticals
11.9.1 Veloxis Pharmaceuticals Company Details
11.9.2 Veloxis Pharmaceuticals Business Overview
11.9.3 Veloxis Pharmaceuticals Solid Organ Transplantation Rejection (SOT) Introduction
11.9.4 Veloxis Pharmaceuticals Revenue in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
11.9.5 Veloxis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Kidney
Table 3. Key Players of Heart
Table 4. Key Players of Liver
Table 5. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million), 2021–2026
Table 8. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region (2021–2026)
Table 9. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region (2027–2032)
Table 11. Solid Organ Transplantation Rejection (SOT) Market Trends
Table 12. Solid Organ Transplantation Rejection (SOT) Market Drivers
Table 13. Solid Organ Transplantation Rejection (SOT) Market Challenges
Table 14. Solid Organ Transplantation Rejection (SOT) Market Restraints
Table 15. Global Solid Organ Transplantation Rejection (SOT) Revenue by Players (US$ Million), 2021–2026
Table 16. Global Solid Organ Transplantation Rejection (SOT) Market Share by Players (2021–2026)
Table 17. Global Top Solid Organ Transplantation Rejection (SOT) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Solid Organ Transplantation Rejection (SOT) Revenue, 2025
Table 18. Ranking of Global Top Solid Organ Transplantation Rejection (SOT) Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Solid Organ Transplantation Rejection (SOT) Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Solid Organ Transplantation Rejection (SOT), Headquarters and Area Served
Table 21. Global Key Players of Solid Organ Transplantation Rejection (SOT), Products and Applications
Table 22. Global Key Players of Solid Organ Transplantation Rejection (SOT), Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Solid Organ Transplantation Rejection (SOT) Market Size by Type (US$ Million), 2021–2026
Table 25. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Type (2021–2026)
Table 26. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Type (2027–2032)
Table 28. Global Solid Organ Transplantation Rejection (SOT) Market Size by Application (US$ Million), 2021–2026
Table 29. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Application (2021–2026)
Table 30. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Application (2027–2032)
Table 32. North America Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026
Table 34. North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Solid Organ Transplantation Rejection (SOT) Product
Table 50. Novartis Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 51. Novartis Recent Development
Table 52. Terumo Company Details
Table 53. Terumo Business Overview
Table 54. Terumo Solid Organ Transplantation Rejection (SOT) Product
Table 55. Terumo Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 56. Terumo Recent Development
Table 57. Roche Company Details
Table 58. Roche Business Overview
Table 59. Roche Solid Organ Transplantation Rejection (SOT) Product
Table 60. Roche Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 61. Roche Recent Development
Table 62. Astellas Pharma Company Details
Table 63. Astellas Pharma Business Overview
Table 64. Astellas Pharma Solid Organ Transplantation Rejection (SOT) Product
Table 65. Astellas Pharma Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 66. Astellas Pharma Recent Development
Table 67. Preservation Solutions Company Details
Table 68. Preservation Solutions Business Overview
Table 69. Preservation Solutions Solid Organ Transplantation Rejection (SOT) Product
Table 70. Preservation Solutions Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 71. Preservation Solutions Recent Development
Table 72. Transmedic Company Details
Table 73. Transmedic Business Overview
Table 74. Transmedic Solid Organ Transplantation Rejection (SOT) Product
Table 75. Transmedic Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 76. Transmedic Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Solid Organ Transplantation Rejection (SOT) Product
Table 80. Pfizer Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 81. Pfizer Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Solid Organ Transplantation Rejection (SOT) Product
Table 85. Sanofi Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 86. Sanofi Recent Development
Table 87. Veloxis Pharmaceuticals Company Details
Table 88. Veloxis Pharmaceuticals Business Overview
Table 89. Veloxis Pharmaceuticals Solid Organ Transplantation Rejection (SOT) Product
Table 90. Veloxis Pharmaceuticals Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 91. Veloxis Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Solid Organ Transplantation Rejection (SOT) Picture
Figure 2. Global Solid Organ Transplantation Rejection (SOT) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Solid Organ Transplantation Rejection (SOT) Market Share by Type: 2025 vs 2032
Figure 4. Kidney Features
Figure 5. Heart Features
Figure 6. Liver Features
Figure 7. Global Solid Organ Transplantation Rejection (SOT) Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Solid Organ Transplantation Rejection (SOT) Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Transplant Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Solid Organ Transplantation Rejection (SOT) Report Years Considered
Figure 13. Global Solid Organ Transplantation Rejection (SOT) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Solid Organ Transplantation Rejection (SOT) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region: 2025 vs 2032
Figure 16. Global Solid Organ Transplantation Rejection (SOT) Market Share by Players in 2025
Figure 17. Global Solid Organ Transplantation Rejection (SOT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Solid Organ Transplantation Rejection (SOT) Revenue in 2025
Figure 19. North America Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)
Figure 21. United States Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)
Figure 25. Germany Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Share by Region (2021–2032)
Figure 33. China Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)
Figure 41. Mexico Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)
Figure 45. Israel Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Novartis Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 49. Terumo Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 50. Roche Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 51. Astellas Pharma Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 52. Preservation Solutions Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 53. Transmedic Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 54. Pfizer Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 55. Sanofi Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 56. Veloxis Pharmaceuticals Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Kidney
Table 3. Key Players of Heart
Table 4. Key Players of Liver
Table 5. Global Solid Organ Transplantation Rejection (SOT) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million), 2021–2026
Table 8. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region (2021–2026)
Table 9. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region (2027–2032)
Table 11. Solid Organ Transplantation Rejection (SOT) Market Trends
Table 12. Solid Organ Transplantation Rejection (SOT) Market Drivers
Table 13. Solid Organ Transplantation Rejection (SOT) Market Challenges
Table 14. Solid Organ Transplantation Rejection (SOT) Market Restraints
Table 15. Global Solid Organ Transplantation Rejection (SOT) Revenue by Players (US$ Million), 2021–2026
Table 16. Global Solid Organ Transplantation Rejection (SOT) Market Share by Players (2021–2026)
Table 17. Global Top Solid Organ Transplantation Rejection (SOT) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Solid Organ Transplantation Rejection (SOT) Revenue, 2025
Table 18. Ranking of Global Top Solid Organ Transplantation Rejection (SOT) Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Solid Organ Transplantation Rejection (SOT) Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Solid Organ Transplantation Rejection (SOT), Headquarters and Area Served
Table 21. Global Key Players of Solid Organ Transplantation Rejection (SOT), Products and Applications
Table 22. Global Key Players of Solid Organ Transplantation Rejection (SOT), Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Solid Organ Transplantation Rejection (SOT) Market Size by Type (US$ Million), 2021–2026
Table 25. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Type (2021–2026)
Table 26. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Type (2027–2032)
Table 28. Global Solid Organ Transplantation Rejection (SOT) Market Size by Application (US$ Million), 2021–2026
Table 29. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Application (2021–2026)
Table 30. Global Solid Organ Transplantation Rejection (SOT) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Solid Organ Transplantation Rejection (SOT) Revenue Market Share by Application (2027–2032)
Table 32. North America Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026
Table 34. North America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size by Country (US$ Million), 2027–2032
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Solid Organ Transplantation Rejection (SOT) Product
Table 50. Novartis Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 51. Novartis Recent Development
Table 52. Terumo Company Details
Table 53. Terumo Business Overview
Table 54. Terumo Solid Organ Transplantation Rejection (SOT) Product
Table 55. Terumo Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 56. Terumo Recent Development
Table 57. Roche Company Details
Table 58. Roche Business Overview
Table 59. Roche Solid Organ Transplantation Rejection (SOT) Product
Table 60. Roche Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 61. Roche Recent Development
Table 62. Astellas Pharma Company Details
Table 63. Astellas Pharma Business Overview
Table 64. Astellas Pharma Solid Organ Transplantation Rejection (SOT) Product
Table 65. Astellas Pharma Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 66. Astellas Pharma Recent Development
Table 67. Preservation Solutions Company Details
Table 68. Preservation Solutions Business Overview
Table 69. Preservation Solutions Solid Organ Transplantation Rejection (SOT) Product
Table 70. Preservation Solutions Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 71. Preservation Solutions Recent Development
Table 72. Transmedic Company Details
Table 73. Transmedic Business Overview
Table 74. Transmedic Solid Organ Transplantation Rejection (SOT) Product
Table 75. Transmedic Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 76. Transmedic Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Solid Organ Transplantation Rejection (SOT) Product
Table 80. Pfizer Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 81. Pfizer Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Solid Organ Transplantation Rejection (SOT) Product
Table 85. Sanofi Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 86. Sanofi Recent Development
Table 87. Veloxis Pharmaceuticals Company Details
Table 88. Veloxis Pharmaceuticals Business Overview
Table 89. Veloxis Pharmaceuticals Solid Organ Transplantation Rejection (SOT) Product
Table 90. Veloxis Pharmaceuticals Revenue in Solid Organ Transplantation Rejection (SOT) Business (US$ Million), 2021–2026
Table 91. Veloxis Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Solid Organ Transplantation Rejection (SOT) Picture
Figure 2. Global Solid Organ Transplantation Rejection (SOT) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Solid Organ Transplantation Rejection (SOT) Market Share by Type: 2025 vs 2032
Figure 4. Kidney Features
Figure 5. Heart Features
Figure 6. Liver Features
Figure 7. Global Solid Organ Transplantation Rejection (SOT) Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Solid Organ Transplantation Rejection (SOT) Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Transplant Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Solid Organ Transplantation Rejection (SOT) Report Years Considered
Figure 13. Global Solid Organ Transplantation Rejection (SOT) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Solid Organ Transplantation Rejection (SOT) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Solid Organ Transplantation Rejection (SOT) Market Share by Region: 2025 vs 2032
Figure 16. Global Solid Organ Transplantation Rejection (SOT) Market Share by Players in 2025
Figure 17. Global Solid Organ Transplantation Rejection (SOT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Solid Organ Transplantation Rejection (SOT) Revenue in 2025
Figure 19. North America Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)
Figure 21. United States Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)
Figure 25. Germany Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Solid Organ Transplantation Rejection (SOT) Market Share by Region (2021–2032)
Figure 33. China Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)
Figure 41. Mexico Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Solid Organ Transplantation Rejection (SOT) Market Share by Country (2021–2032)
Figure 45. Israel Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Solid Organ Transplantation Rejection (SOT) Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Novartis Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 49. Terumo Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 50. Roche Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 51. Astellas Pharma Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 52. Preservation Solutions Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 53. Transmedic Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 54. Pfizer Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 55. Sanofi Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 56. Veloxis Pharmaceuticals Revenue Growth Rate in Solid Organ Transplantation Rejection (SOT) Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232